Pulmonology Lasers Market: By Laser Type (Photodynamic and Neodymium-doped Yttrium Aluminium Garnet), Application (Haemorrhage, Neoplasms, Malignant Lesions, Tracheal Stenosis, Bronchogenic Carcinoma, Non-Small Cell Lung Cancer (Cystic Carcinoma, Carcinoid, Endobronchial Metastases and Mucoepidermoid Carcinoma) and Benign Tumours), End-user (Academic and Research Institutions, Hospitals and Specialty Care Centres),and Geography

Pulmonology Lasers Market size was valued at USD 5.381.6 million in 2023 and poised to grow at 12.7% CAGR during the forecast years (2024-2030). Pulmonology lasers are medical devices specifically applied in treating various conditions related to respiratory problems, especially those procedures performed on the lungs and airways. These lasers are used in minimally invasive surgeries for tumor removal, unblocking obstructions, or treating diseases such as lung cancer, chronic obstructive pulmonary disease, and tracheal or bronchial stenosis. The increasing incidence of respiratory conditions such as lung cancer, COPD, and asthma is a significant driver of the pulmonology lasers market. According to OHID, this had risen to 1.1 million respiratory hospital admissions in 2019-2020, up 49% compared to 2009-2010. This increase highlights the growing pressure that respiratory conditions are putting on the health system.

However, one major restraint exists in developing regions where healthcare budgets may not allow for the high cost of acquisition and maintenance of laser systems. Additionally, a lack of specialized human resources can hence hinder the full diffusion and optimal exploitation of these advanced technologies in relatively poor regions. Due to a reduced recovery time and the risk of complications, minimally invasive surgery is the most popular and can be seen as an opportunity for the Pulmonary Lasers Market.

Pulmonology Lasers Market Key Developments:

• In 2022: The Department of Pulmonary Medicine in Government Medical College, Srinagar, was one of the very few centers in J&K, India, that implemented laser technology in the interventional pulmonology department.
• In2020: Olympus Corporation acquired Veran Medical Technologies, Inc. in a bid to expand its respiratory products portfolio. Veran Medical Technologies is a leading service provider in the interventional pulmonology section. The acquisition was carried out for USD 340 million and was implemented through the Olympus Corporation of the Americas (OCA).